Research and Reviews: A Journal of Toxicology
E-ISSN: 2231-3834
Editor Overview
rrjot maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Publisher
STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
E-mail:
[email protected]
Phone:
(+91)-0120- 4781-200
Mobile:
(+91)-981-007-8958
(+91)-966-7725-932
About the Journal
Research & Reviews: A Journal of Toxicology [2231-3834 (e)] is a peer-reviewed open access journal launched in 2011 and focused on the publication of current research work carried out under Toxicology. It is concerned with the harmful effects of
View full focus & scope 
Journal Particulars
✉ [email protected]
Latest Articles
Volume: 15, Issue: 01, Year: 2025
Sudhin Varghese
Keywords: Nanoparticles, environmental pollutants, toxicity, public health, nanotoxicology, oxidative stress
Dr. Sushma Muchukota, Pavithra S, Dr. Shobha Rani R. Hiremath
Keywords: Honey bee venom (HBV), anticancer mechanisms, melittin, apoptosis, angiogenesis inhibition, metastasis suppression, immune modulation
Zainab Salah Abdul-Jabbar
Keywords: Sweeteners , islets of Langerhans, Aspartame, infiltrates , lymphocytes.
Megha Majoe
Keywords: Asthma, Asystasia gangetica, IL-5, TRPA1, IL1RL1, Palustrol
Archana Reddy
Keywords: Toxicology, toxicants, toxins, poisons, industrialization, environmental toxins.
Special Issues
Journal Menu
Artificial Intelligence in Drug Delivery
Abstract Submission Deadline : 30/11/2023
Manuscript Submission Deadline : 25/12/2023
Special Issue Description
Interventional pharmacology is one of medicine’s strong weapons against diseases. These drugs, be that as they may, can result in harmful side impacts and must be closely observed. Pharmacovigilance is the field of science that screens recognizes, and avoids adverse drug reactions (ADRs). Security efforts start amid the advancement handle, utilizing in vivo and in vitro studies, proceed through clinical trials, and amplify to the postmarketing observation of ADRs in real-world populaces. The utilization of artificial intelligence (AI) has been expanding in different segments of society, especially the pharmaceutical industry. In this survey, we highlight the utilization of AI in different divisions of the pharmaceutical industry, counting medicate disclosure and advancement, drug repurposing, making strides in pharmaceutical efficiency, and clinical trials, among others; such utilization decreases the human workload as well as accomplishing targets in a brief period. With the consideration of AI within the manufacturing of pharmaceutical products, personalized drugs with the specified measurements, discharge parameters, and other required perspectives can be manufactured agreeing to patients’ needs required. Utilizing the most recent AI-based advances will not as it was speeding up the time required for the items to come to the advertising, but will too make strides in the quality of items and the general security of the production process, and give superior utilization of accessible assets alongside being cost-effective, subsequently expanding the significance of automation.
Keywords
Adverse drug reactions (ADRs), Artificial Intelligence (AI), Drugs, Pharmaceutical, Diseases
Manuscript Submission information
Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.
Participating journals:
Journal Name
Research & Reviews: A Journal of Toxicology, Research & Reviews: A Journal of Toxicology
Abbrivation
ISSN
Since
2010
APC
950 $